Related Experiment Videos
[Spina bifida: prevention policy can be more effective]
1Emma Kinderziekenhuis-AMC, afd. Kinderneurologie, DE Amsterdam. p.g.barth@amc.uva.nl
Nederlands Tijdschrift Voor Geneeskunde
|September 19, 2000
Summary
Spina bifida rates remain high despite increased folic acid use. Further prevention may be possible with second-trimester ultrasound screening, warranting further study.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Medical Genetics
Background:
- Spina bifida, a severe neural tube defect, shows decreasing but still unacceptably high prevalence.
- Current folic acid supplementation compliance among women planning pregnancy is only one-third, though increasing.
- Folic acid supplementation alone cannot completely prevent spina bifida.
Purpose of the Study:
- To highlight the need for intensified folic acid use campaigns.
- To explore additional prevention strategies for spina bifida.
- To investigate the potential of second-trimester ultrasound screening for secondary prevention.
Main Methods:
- Review of current spina bifida prevalence data.
- Analysis of folic acid compliance rates.
- Discussion of ultrasound screening as a secondary prevention method.
Main Results:
- Despite efforts, spina bifida rates remain a significant public health concern.
- Folic acid use is increasing but insufficient for complete prevention.
- Ultrasound screening in the second trimester presents a potential avenue for further reduction.
Conclusions:
- Intensified folic acid campaigns are crucial but insufficient on their own.
- Second-trimester ultrasound screening should be urgently studied for its role in secondary spina bifida prevention.
- A combined approach of primary and secondary prevention may be necessary to further reduce spina bifida incidence.